vs

Side-by-side financial comparison of Cellectis S.A. (CLLS) and Pathfinder Bancorp, Inc. (PBHC). Click either name above to swap in a different company.

Pathfinder Bancorp, Inc. is the larger business by last-quarter revenue ($11.8M vs $9.5M, roughly 1.2× Cellectis S.A.). Pathfinder Bancorp, Inc. runs the higher net margin — -52.9% vs -265.9%, a 212.9% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs -22.6%). Cellectis S.A. produced more free cash flow last quarter ($27.6M vs $10.4M).

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Pathfinder Bancorp, Inc. is a regional bank holding company headquartered in New York, U.S. It operates Pathfinder Bank serving the central New York market, offering retail and commercial banking services including deposit accounts, mortgages, business loans and wealth management for individual consumers and small to medium-sized enterprises.

CLLS vs PBHC — Head-to-Head

Bigger by revenue
PBHC
PBHC
1.2× larger
PBHC
$11.8M
$9.5M
CLLS
Growing faster (revenue YoY)
CLLS
CLLS
+397.6% gap
CLLS
375.0%
-22.6%
PBHC
Higher net margin
PBHC
PBHC
212.9% more per $
PBHC
-52.9%
-265.9%
CLLS
More free cash flow
CLLS
CLLS
$17.2M more FCF
CLLS
$27.6M
$10.4M
PBHC

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
CLLS
CLLS
PBHC
PBHC
Revenue
$9.5M
$11.8M
Net Profit
$-25.3M
$-5.6M
Gross Margin
Operating Margin
-181.1%
-81.1%
Net Margin
-265.9%
-52.9%
Revenue YoY
375.0%
-22.6%
Net Profit YoY
-51.9%
-242.4%
EPS (diluted)
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLLS
CLLS
PBHC
PBHC
Q4 25
$11.8M
Q3 25
$13.1M
Q2 25
$9.3M
Q1 25
$12.6M
Q4 24
$15.3M
Q3 24
$13.4M
Q2 24
$9.5M
$10.7M
Q1 24
$11.1M
Net Profit
CLLS
CLLS
PBHC
PBHC
Q4 25
$-5.6M
Q3 25
$626.0K
Q2 25
$31.0K
Q1 25
$3.0M
Q4 24
$3.9M
Q3 24
$-4.6M
Q2 24
$-25.3M
$2.0M
Q1 24
$2.1M
Operating Margin
CLLS
CLLS
PBHC
PBHC
Q4 25
-81.1%
Q3 25
5.1%
Q2 25
0.4%
Q1 25
29.5%
Q4 24
55.4%
Q3 24
-43.1%
Q2 24
-181.1%
23.3%
Q1 24
24.3%
Net Margin
CLLS
CLLS
PBHC
PBHC
Q4 25
-52.9%
Q3 25
4.8%
Q2 25
0.3%
Q1 25
23.6%
Q4 24
37.7%
Q3 24
-34.6%
Q2 24
-265.9%
18.7%
Q1 24
19.0%
EPS (diluted)
CLLS
CLLS
PBHC
PBHC
Q4 25
Q3 25
$0.47
Q2 25
$0.47
Q1 25
Q4 24
Q3 24
$0.41
Q2 24
$-0.28
$0.41
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLLS
CLLS
PBHC
PBHC
Cash + ST InvestmentsLiquidity on hand
$149.0M
Total DebtLower is stronger
$14.1M
Stockholders' EquityBook value
$148.6M
$122.5M
Total Assets
$407.1M
$1.4B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLLS
CLLS
PBHC
PBHC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$149.0M
Q1 24
Total Debt
CLLS
CLLS
PBHC
PBHC
Q4 25
$14.1M
Q3 25
$18.7M
Q2 25
$21.0M
Q1 25
$17.6M
Q4 24
$27.1M
Q3 24
$39.8M
Q2 24
$45.9M
Q1 24
$45.9M
Stockholders' Equity
CLLS
CLLS
PBHC
PBHC
Q4 25
$122.5M
Q3 25
$126.3M
Q2 25
$124.4M
Q1 25
$124.9M
Q4 24
$121.5M
Q3 24
$120.2M
Q2 24
$148.6M
$123.3M
Q1 24
$121.8M
Total Assets
CLLS
CLLS
PBHC
PBHC
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$407.1M
$1.4B
Q1 24
$1.5B
Debt / Equity
CLLS
CLLS
PBHC
PBHC
Q4 25
0.11×
Q3 25
0.15×
Q2 25
0.17×
Q1 25
0.14×
Q4 24
0.22×
Q3 24
0.33×
Q2 24
0.37×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLLS
CLLS
PBHC
PBHC
Operating Cash FlowLast quarter
$28.9M
$11.7M
Free Cash FlowOCF − Capex
$27.6M
$10.4M
FCF MarginFCF / Revenue
290.5%
88.1%
Capex IntensityCapex / Revenue
13.2%
10.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLLS
CLLS
PBHC
PBHC
Q4 25
$11.7M
Q3 25
$7.0M
Q2 25
$-3.7M
Q1 25
$5.7M
Q4 24
$11.2M
Q3 24
$11.8M
Q2 24
$28.9M
$1.5M
Q1 24
$504.0K
Free Cash Flow
CLLS
CLLS
PBHC
PBHC
Q4 25
$10.4M
Q3 25
$6.9M
Q2 25
$-4.0M
Q1 25
$5.1M
Q4 24
$9.1M
Q3 24
$11.3M
Q2 24
$27.6M
$637.0K
Q1 24
$274.0K
FCF Margin
CLLS
CLLS
PBHC
PBHC
Q4 25
88.1%
Q3 25
52.8%
Q2 25
-42.6%
Q1 25
40.1%
Q4 24
59.9%
Q3 24
84.3%
Q2 24
290.5%
6.0%
Q1 24
2.5%
Capex Intensity
CLLS
CLLS
PBHC
PBHC
Q4 25
10.7%
Q3 25
1.0%
Q2 25
2.4%
Q1 25
5.1%
Q4 24
13.5%
Q3 24
3.8%
Q2 24
13.2%
8.2%
Q1 24
2.1%
Cash Conversion
CLLS
CLLS
PBHC
PBHC
Q4 25
Q3 25
11.26×
Q2 25
-120.55×
Q1 25
1.92×
Q4 24
2.87×
Q3 24
Q2 24
0.76×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLLS
CLLS

Segment breakdown not available.

PBHC
PBHC

Other$5.6M47%
Banking$3.7M31%
Deposit Account$1.5M13%
Financial Service Other$1.0M9%

Related Comparisons